litlas
Log inCreate account

Jürgen Behr

Active 1990–2025

182
Papers
27,631
Citations
78
h-index
165
i10-index

Citations

Citations per year for Jürgen Behr1960: 2 citations1993: 2 citations1994: 2 citations1996: 2 citations1997: 6 citations1998: 7 citations1999: 15 citations2000: 17 citations2001: 28 citations2002: 24 citations2003: 43 citations2004: 58 citations2005: 69 citations2006: 82 citations2007: 77 citations2008: 125 citations2009: 103 citations2010: 90 citations2011: 77 citations2012: 80 citations2013: 115 citations2014: 109 citations2015: 113 citations2016: 142 citations2017: 152 citations2018: 169 citations2019: 877 citations2020: 1,080 citations2021: 1,188 citations2022: 1,086 citations2023: 797 citations2024: 1,330 citations2025: 544 citations2026: 16 citations1961–1992: no citations, so these years are not shown1995: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,504 citing papers, 22% of this breakdownGermany: 946 citing papers, 8.3% of this breakdownChina: 931 citing papers, 8.2% of this breakdownUnited Kingdom: 870 citing papers, 7.6% of this breakdownItaly: 713 citing papers, 6.2% of this breakdownJapan: 588 citing papers, 5.1% of this breakdownFrance: 544 citing papers, 4.8% of this breakdownCanada: 493 citing papers, 4.3% of this breakdownAustralia: 338 citing papers, 3% of this breakdownNetherlands: 328 citing papers, 2.9% of this breakdownSpain: 320 citing papers, 2.8% of this breakdownSwitzerland: 237 citing papers, 2.1% of this breakdown
0%22%Other 22.7%

Institutions

Fields

  • Medicine81.4%
  • Biochemistry, Genetics and Molecular Biology8.6%
  • Immunology and Microbiology3%
  • Neuroscience1.8%
  • Agricultural and Biological Sciences1.4%
  • Engineering0.8%
  • Other3%

Topics

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis18.2%
  • Pulmonary Hypertension Research and Treatments5.3%
  • Chronic Obstructive Pulmonary Disease (COPD) Research4.9%
  • Systemic Sclerosis and Related Diseases4.5%
  • Sarcoidosis and Beryllium Toxicity Research3.2%
  • Medical Imaging and Pathology Studies2.6%
  • Other61.3%

Coauthors

All papers

Open in search
  1. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

    Authors: Ganesh Raghu, Martine Rémy‐Jardin, Jeffrey L. Myers, Luca Richeldi, Christopher J. Ryerson, David J. Lederer, Jürgen Behr, Vincent Cottin, Sonye K. Danoff, Ferrán Morell, Kevin Flaherty, Athol U. Wells, Fernando J. Martínez, Arata Azuma, Thomas Bice, Demosthenes Bouros, Kevin M. Brown, Harold R. Collard, Abhijit Duggal, Liam Galvin, Yoshikazu Inoue, Gísli Jenkins, Takeshi Johkoh, Ella A. Kazerooni, Masanori Kitaichi, Shandra L. Knight, George Mansour, Andrew G. Nicholson, Sudhakar Pipavath, Ivette Buendía-Roldán, Moisés Selman, William D. Travis, Simon Walsh, Kevin C. Wilson - American Journal of Respiratory and Critical Care Medicine 2018 cited by 4,100

  2. An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

    Authors: William D. Travis, Ulrich Costabel, David M. Hansell, Talmadge E. King, David A. Lynch, Andrew G. Nicholson, Christopher J. Ryerson, Jay H. Ryu, Moisés Selman, Athol U. Wells, Jürgen Behr, Demosthenes Bouros, Kevin M. Brown, Thomas V. Colby, Harold R. Collard, Carlos Robalo Cordeiro, Vincent Cottin, Bruno Crestani, Marjolein Drent, Rosalind F. Dudden, Jim Egan, Kevin R. Flaherty, Cory M. Hogaboam, Yoshikazu Inoue, Takeshi Johkoh, Dong Soon Kim, Masanori Kitaichi, James E. Loyd, Fernando J. Martínez, Jeffrey L. Myers, Shandra Protzko, Ganesh Raghu, Luca Richeldi, Nicola Sverzellati, Jeffrey J. Swigris, Dominique Valeyre - American Journal of Respiratory and Critical Care Medicine 2013 cited by 4,273

  3. Alveolar regeneration through a Krt8+ transitional stem cell state that persists in human lung fibrosis

    Authors: Maximilian Strunz, Lukas M. Simon, Meshal Ansari, Jaymin J. Kathiriya, Ilias Angelidis, Christoph H. Mayr, George Tsidiridis, Marius Lange, Laura F. Mattner, Min Yee, Paulina Ogar, Arunima Sengupta, I. V. Kukhtevich, Robert Schneider, Zhongming Zhao, Carola Voss, Tobias Stoeger, Jens Neumann, Anne Hilgendorff, Jürgen Behr, Michael A. O’Reilly, Mareike Lehmann, Gerald Burgstaller, Mélanie Königshoff, Harold A. Chapman, Fabian J. Theis, Herbert B. Schiller - Nature Communications 2020 cited by 748

  4. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report

    Authors: Harold R. Collard, Christopher J. Ryerson, Tamera J. Corte, Gísli Jenkins, Yasuhiro Kondoh, David J. Lederer, Joyce Lee, Toby M. Maher, Athol U. Wells, Κατερίνα Αντωνίου, Jürgen Behr, Kevin M. Brown, Vincent Cottin, Kevin R. Flaherty, Junya Fukuoka, David M. Hansell, Takeshi Johkoh, Naftali Kaminski, Dong Soon Kim, Martin Kolb, David A. Lynch, Jeffrey L. Myers, Ganesh Raghu, Luca Richeldi, Hiroyuki Taniguchi, Fernando J. Martínez - American Journal of Respiratory and Critical Care Medicine 2016 cited by 1,444

  5. Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

    Authors: Jürgen Behr, Antje Prasse, Michael Kreuter, Johannes Johow, Klaus F. Rabe, Francesco Bonella, R. Bonnet, Christian Grohé, Matthias Held, Heinrike Wilkens, Peter Hammerl, Dirk Koschel, Stefan Blaas, Hubert Wirtz, Joachim H. Ficker, Wolfgang Neumeister, Nicolas Schönfeld, Martin Claussen, Nikolaus Kneidinger, Marion Frankenberger, Simone Hummler, Nicolas Kahn, Silke Tello, Julia Freise, Tobias Welte, Petra Neuser, Andreas Günther, Jürgen Behr, Michael Kreuter, Johannes Johow, Klaus F. Rabe, Francesco Bonella, R. Bonnet, Christian Grohé, Matthias Held, Heinrike Wilkens, Peter Hammerl, Dirk Koschel, Stefan Blaas, Hubert Wirtz, Joachim H. Ficker, Wolfgang Neumeister, N Schönfeld, Martin Claussen, Nikolaus Kneidinger, Marion Frankenberger, Simone Hummler, Nicolas Kahn, Silke Tello, Julia Freise, Tobias Welte, Petra Neuser, Andreas Günther, Carmen Schade‐Brittinger, Behnaz Aminossadati, Christian Nasemann, Soraya Yahiaoui, Christoph Dupuy Backofen, Maik Hahmann, Michael Wittenberg, Fotis Drakopanagiotakis, Daniel von der Beck, Stefanie Ghofrani, S Heinemann, Ekaterina Krauss, Hella Rethorn, Andrea Koch, Gabriela Leuschner, Sandhya Matthes, Claus Neurohr, Tobias Veit, Katrin Milger, Felix Herth, Julia Benstz, Simone Hummler, Thomas Bahmer, Heike Biller, Benjamin Waschki, Rosa-Marie Apel, Ulrich Costabel, Eva Börner, Thomas Wessendorf, M. Arnrich, Lacramioara Ilie, Alexandra Wald, Hans‐Jürgen Seyfarth, Christian Reinhardt, Atif Cinar, Markus Vogler, Siegfried Matthias Huhn, Jaqueline Richter, U Neff, Torsten Blum, Silvan Vesenbeckh, Christian Boch, Hannes Semper, Andreas Wilke, Michael Pfeifer, Annette Schweda, Angelika Krill and 7 more - The Lancet Respiratory Medicine 2021 cited by 516

  6. Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study

    Authors: Steven D. Nathan, Jürgen Behr, Harold R. Collard, Vincent Cottin, Marius M. Hoeper, Fernando J. Martínez, Tamera J. Corte, Anne Keogh, Hanno Leuchte, Nesrin Moğulkoç, Silvia Ulrich, Wim Wuyts, Zhen Yao, Francis Boateng, Athol U. Wells - The Lancet Respiratory Medicine 2019 cited by 241

  7. Radiation-induced lung toxicity – cellular and molecular mechanisms of pathogenesis, management, and literature review

    Authors: Lukas Käsmann, Alexander Dietrich, Claudia A. Staab-Weijnitz, Farkhad Manapov, Jürgen Behr, Andreas Rimner, Branislav Jeremić, Suresh Senan, Dirk De Ruysscher, Kirsten Lauber, Claus Belka - Radiation Oncology 2020 cited by 235

  8. Response to Biologics and Clinical Remission in the Adult German Asthma Net Severe Asthma Registry Cohort

    Authors: Katrin Milger, Hendrik Suhling, Dirk Skowasch, Annette Holtdirk, Nikolaus Kneidinger, Jürgen Behr, Hartmut Timmermann, Christian Schulz, Olaf Schmidt, Rainer Ehmann, Eckard Hamelmann, Marco Idzko, Christian Taube, Marek Lommatzsch, Roland Buhl, Stephanie Korn - The Journal of Allergy and Clinical Immunology In Practice 2023 cited by 86

  9. A Phase IIb Randomized Clinical Study of an Anti-αvβ6 Monoclonal Antibody in Idiopathic Pulmonary Fibrosis

    Authors: Ganesh Raghu, Majd Mouded, Daniel C. Chambers, Fernando J. Martínez, Luca Richeldi, Lisa Lancaster, Mark J. Hamblin, Kevin F. Gibson, Iván O. Rosas, Antje Prasse, Guolin Zhao, Michael Serenko, Natasha Novikov, Amy McCurley, Prashant Bansal, Christopher Stebbins, Million Arefayene, Stella Ibebunjo, Shelia M. Violette, Diana Gallagher, Jürgen Behr - American Journal of Respiratory and Critical Care Medicine 2022 cited by 101

  10. Ex vivo tissue perturbations coupled to single-cell RNA-seq reveal multilineage cell circuit dynamics in human lung fibrogenesis

    Authors: Niklas J. Lang, Janine Gote-Schniering, Diana Porras-Gonzalez, Lin Yang, Laurens De Sadeleer, R. Christoph Jentzsch, Vladimir A. Shitov, Shuhong Zhou, Meshal Ansari, Ahmed Agami, Christoph H. Mayr, Baharak Hooshiar Kashani, Yuexin Chen, Lukas Heumos, Jeanine C. Pestoni, Eszter Molnár, Emiel Geeraerts, Vincent Anquetil, Laurent Sanière, Melanie Wögrath, Michael Gerckens, Mareike Lehmann, Ali Önder Yildirim, Rudolf Hatz, Nikolaus Kneidinger, Jürgen Behr, Wim Wuyts, Mircea Gabriel Stoleriu, Malte D. Luecken, Fabian J. Theis, Gerald Burgstaller, Herbert B. Schiller - Science Translational Medicine 2023 cited by 79

  11. Efficacy and safety of sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: a double-blind, randomised, placebo-controlled, phase 2b trial

    Authors: Jürgen Behr, Steven D. Nathan, Wim Wuyts, Nesrin Mogulkoc Bishop, Demosthenes Bouros, Κατερίνα Αντωνίου, Julien Guiot, Mordechai R. Kramer, Klaus-Uwe Kirchgaessler, Monica Bengus, Frank Gilberg, Andras Perjesi, Sergio Harari, Athol U. Wells - The Lancet Respiratory Medicine 2020 cited by 134

  12. The Diagnosis and Treatment of COPD and Its Comorbidities.

    Authors: Kathrin Kahnert, Rudolf A. Jörres, Jürgen Behr, Tobias Welte - Deutsches Ärzteblatt international 2023 cited by 117

  13. Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review

    Authors: Ganesh Raghu, Valeria C. Amatto, Jürgen Behr, Susanne Stowasser - European Respiratory Journal 2015 cited by 463

  14. Sfrp1 inhibits lung fibroblast invasion during transition to injury-induced myofibroblasts

    Authors: Christoph H. Mayr, Arunima Sengupta, Sara Asgharpour, Meshal Ansari, Jeanine C. Pestoni, Paulina Ogar, Ilias Angelidis, Andreas Liontos, José Alberto Rodríguez‐Castillo, Niklas J. Lang, Maximilian Strunz, Diana Porras-Gonzalez, Michael Gerckens, Laurens De Sadeleer, Bettina Oehrle, Valeria Viteri-Alvarez, Isis E. Fernandez, Michelle D. Tallquist, Martin Irmler, Johannes Beckers, Oliver Eickelberg, Gabriel Stoleriu, Jürgen Behr, Nikolaus Kneidinger, Wim Wuyts, Roxana Wasnick, Ali Önder Yildirim, Katrin Ahlbrecht, Rory E. Morty, Christos Samakovlis, Fabian J. Theis, Gerald Burgstaller, Herbert B. Schiller - European Respiratory Journal 2024 cited by 101

  15. Inhaled Iloprost for Severe Pulmonary Hypertension

    Authors: Horst Olschewski, Gérald Simonneau, Nazzareno Galiè, T. W. Higenbottam, Robert Naeije, Lewis J. Rubin, Sylvia Nikkho, Rudolf Speich, Marius M. Hoeper, Jürgen Behr, Jörg Winkler, Olivier Sitbon, Wladimir Popov, Hossein Ardeschir Ghofrani, Alessandra Manes, David G. Kiely, R Ewert, Andreas Meyer, Paul A. Corris, Marion Delcroix, Miguel Ángel Gómez‐Sánchez, Harald Siedentop, Werner Seeger - New England Journal of Medicine 2002 cited by 1,781

  16. Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry

    Authors: Jürgen Behr, Antje Prasse, Hubert Wirtz, Dirk Koschel, David Pittrow, Matthias Held, Jens Klotsche, Stefan Andreas, Martin Claussen, Christian Grohé, Heinrike Wilkens, Lars Hagmeyer, Dirk Skowasch, Joachim Meyer, J Kirschner, Sven Gläser, Nicolas Kahn, Tobias Welte, Claus Neurohr, Martin Schwaiblmair, Thomas Bahmer, Tim Oqueka, Marion Frankenberger, Michael Kreuter - European Respiratory Journal 2020 cited by 189

  17. Increased Extracellular Vesicles Mediate WNT5A Signaling in Idiopathic Pulmonary Fibrosis

    Authors: Aina Martín-Medina, Mareike Lehmann, Olivier Burgy, Sarah Hermann, Hoeke A. Baarsma, Darcy E. Wagner, Martina M. De Santis, Florian Ciolek, Thomas P. Hofer, Marion Frankenberger, Michaela Aichler, Michael Lindner, Wolfgang Gesierich, Andreas Günther, Axel Walch, Christina Coughlan, Paul J. Wolters, Joyce Lee, Jürgen Behr, Mélanie Königshoff - American Journal of Respiratory and Critical Care Medicine 2018 cited by 187

  18. Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis

    Authors: Martin Kolb, Ganesh Raghu, Athol U. Wells, Jürgen Behr, Luca Richeldi, Birgit Schinzel, Manuel Quaresma, Susanne Stowasser, Fernando J. Martínez - New England Journal of Medicine 2018 cited by 259

  19. Integrative analysis of cell state changes in lung fibrosis with peripheral protein biomarkers

    Authors: Christoph H. Mayr, Lukas M. Simon, Gabriela Leuschner, Meshal Ansari, Janine Gote-Schniering, Philipp E. Geyer, Ilias Angelidis, Maximilian Strunz, Pawandeep Singh, Nikolaus Kneidinger, Frank Reichenberger, Edith Silbernagel, Stephan Böhm, Heiko Adler, Michael Lindner, Britta Maurer, Anne Hilgendorff, Antje Prasse, Jürgen Behr, Matthias Mann, Oliver Eickelberg, Fabian J. Theis, Herbert B. Schiller - EMBO Molecular Medicine 2021 cited by 103

  20. Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on ‘Feels, Functions, Survives’. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory Agency

    Authors: Ganesh Raghu, Marya Ghazipura, Thomas R. Fleming, Kerri I. Aronson, Jürgen Behr, Kevin M. Brown, Kevin R. Flaherty, Ella A. Kazerooni, Toby M. Maher, Luca Richeldi, Joseph A. Lasky, Jeffrey J. Swigris, Robert Busch, Lili Garrard, Dong-Hyun Ahn, Ji Li, Khalid Puthawala, Gabriela Rodal, Sally Seymour, Nargues Weir, Sonye K. Danoff, Neil Ettinger, Jonathan Goldin, Marilyn K. Glassberg, Letícia Kawano-Dourado, Nasreen Khalil, Lisa Lancaster, David A. Lynch, Yolanda Mageto, Imre Noth, Jessica Shore, Marlies Wijsenbeek, Robert S. Brown, Daniel Grogan, Dorothy Ivey, Patrycja Golińska, Banu A. Karimi-Shah, Fernando J. Martínez - American Journal of Respiratory and Critical Care Medicine 2024 cited by 76

  21. Differential effects of Nintedanib and Pirfenidone on lung alveolar epithelial cell function in ex vivo murine and human lung tissue cultures of pulmonary fibrosis

    Authors: Mareike Lehmann, Lara Buhl, Hani N. Alsafadi, Stephan Klee, Sarah Hermann, Kathrin Mutze, Chiharu Ota, Michael Lindner, Jürgen Behr, Anne Hilgendorff, Darcy E. Wagner, Mélanie Königshoff - Respiratory Research 2018 cited by 142

  22. Systemic inflammation and pro-inflammatory cytokine profile predict response to checkpoint inhibitor treatment in NSCLC: a prospective study

    Authors: Diego Kauffmann‐Guerrero, Kathrin Kahnert, Rosemarie Kiefl, Laura Sellmer, Julia Walter, Jürgen Behr, Amanda Tufman - Scientific Reports 2021 cited by 72

  23. Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis

    Authors: Steven D. Nathan, Jürgen Behr, Vincent Cottin, Lisa Lancaster, Peter Smith, CQ Deng, Natalie Breytenbach, Heidi Bell, Leigh Peterson, Kevin R. Flaherty - BMJ Open Respiratory Research 2022 cited by 67

  24. BUILD-1: A Randomized Placebo-controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis

    Authors: Talmadge E. King, Jürgen Behr, Kevin M. Brown, Roland M. du Bois, Lisa Lancaster, João A. de Andrade, G. Stähler, Isabelle Leconte, Sébastiên Roux, Ganesh Raghu - American Journal of Respiratory and Critical Care Medicine 2007 cited by 498